We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CPNG:NYSECoupang, Inc. Analysis

Data as of 2026-03-10 - not real-time

$19.17

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Coupang's stock is trading below its short‑term moving averages – the price sits under the 20‑day SMA, which itself is beneath the 50‑day and 200‑day SMAs, signaling a bearish technical backdrop. Momentum indicators are neutral: RSI hovers around the 50‑point midpoint and the MACD histogram is modestly positive, offering a faint bullish hint but not enough to offset the prevailing downtrend. Volatility remains elevated at nearly 58% over the past month, and beta is just above one, indicating price swings in line with the broader market while the volume trend appears stable.
Fundamentally, the company posts solid top‑line growth with revenue up roughly 11% year‑over‑year, yet profitability is razor‑thin and earnings per share remain in the negative‑to‑low‑positive range. Valuation metrics are stretched – a trailing P/E north of 170 and a price‑to‑book above 7, while the discounted‑cash‑flow model suggests a fair value near $11, well below the current $19 price, flagging the stock as overvalued. The absence of any dividend, combined with heightened regulatory scrutiny from a recent data‑breach incident and an emerging class‑action lawsuit, adds further downside pressure. Investors should weigh the growth narrative against these valuation and risk headwinds.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages indicating bearish bias
  • Support level near $16.9 provides a cushion but upside limited
  • Regulatory uncertainty from data‑breach and pending litigation

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of ~10% and improving forward earnings outlook
  • Potential earnings acceleration as operating efficiencies improve
  • Market positioning in fast‑growing Asian e‑commerce segment

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Long‑term expansion opportunities across logistics and fintech services
  • Sustained high valuation relative to intrinsic fair value
  • Ongoing regulatory and competitive pressures in core markets

Key Metrics & Analysis

Financial Health

Revenue Growth10.90%
Profit Margin0.60%
P/E Ratio174.2
ROE4.86%
ROA1.88%
Debt/Equity100.26
P/B Ratio7.6
Op. Cash Flow$1.8B
Free Cash Flow$843.5M

Technical Analysis

TrendBearish
RSI49.7
Support$16.92
Resistance$20.34
MA 20$18.53
MA 50$20.11
MA 200$27.03
MACDBullish
VolumeStable
Fear & Greed Index80.96

Valuation

Fair Value$11.04
Target Price$27.33
Upside/Downside42.60%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.04
Volatility57.85%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.